EUVIMEDEUVIMED entdecken
Crossref

Inter-hospital heterogeneity in the authorizations of off-label cancer drugs: A project by Associazione Italiana di Oncologia Medica

Anna Amela Valsecchi iD, Matilde Scaldaferri iD, Marcello Tiseo, Gianmauro Numico iD, Gianluca Russo, Nicola Personeni iD, Livio Blasi, Alessia Pisterna, Alessandra Zanardi, Claudia Fruttero, Giordano Domenico Beretta, Giulia Dusi und 5 weitere

Tumori Journal · 2025

DOI: 10.1177/03008916251386285 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tumori Journal, 2025. Verfasst von Anna Amela Valsecchi und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, University of Turin, A.O.U. Città della Salute e della Scienza di Torino, Ospedale Molinette, Turin, Italy. Hauptthemen laut MEDLINE: Off-Label Use, Antineoplastic Agents, Neoplasms. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This project aimed to describe variability of local evaluations of off-label cancer drug requests by submitting a list of identical requests to different Italian centers.

Methods

In October 2024, oncology unit directors listed in the AIOM Libro Bianco were invited to participate, evaluating 11 clinical cases with solid tumors through their internal approval process. Supporting evidence was retrospective in two cases, based on phase II trials in seven, and phase III trials in two. Inter-rater agreement was measured using Fleiss’ kappa.

Results

Seven centers completed evaluations. Two cases were approved by all centers, both with a rare cancer with scant alternatives. The mean number of centers approving the individual requests was 5.36/7 (76.6%) with a poor inter-rater agreement (kappa 0.009, 95% CI -0.120 to 0.138). Single centers approved a mean of 8.4 requests (76.6%). The mean number of centers that approved requests was 5.5 for requests based on retrospective studies, 5.3 for those based on phase II trials, and 5.5 for those based on phase III trials. There was no correlation between estimated cost and chance of approval.

Conclusions

There is a significant inter-hospital variability in off-label oncology drug evaluations, leading to potential disparities in patient’s access to care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Off-Label UseAntineoplastic AgentsNeoplasmsHumansItalyRetrospective StudiesClinical Trials, Phase III as TopicMedical OncologyClinical Trials, Phase II as TopicDrug ApprovalHospitals

Stichwörter der Autor:innen

AIOMOff-labelcancer drugsinter-hospital heterogeneitylaw 94/98

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Oncology, University of Turin, A.O.U. Città della Salute e della Scienza di Torino, Ospedale Molinette, Turin, Italy.
  • SC Farmacia Ospedaliera, AOU Città della Salute e della Scienza di Torino, Turin, Italy.
  • UOC Oncologia Medica, Azienda Ospedaliero-Universitaria di Parma; Dipartimento di Medicina e Chirurgia, Università di Parma, Parma, Italy.
  • SC Oncologia AO S. Croce e Carle, Cuneo, Italy.
  • UOC Oncologia Medica, Presidio Ospedaliero di Pescara, Pescara, Italy.
  • SC Oncologia, Polo Oncologico P.O. Manerbio, ASST del Garda, Manerbio, Italy.

ORCID-Profile: Anna Amela Valsecchi, Matilde Scaldaferri, Gianmauro Numico, Nicola Personeni, Massimo Di Maio

Zitieren

APA

Valsecchi, A. A., Scaldaferri, M., Tiseo, M., Numico, G., Russo, G., Personeni, N., Blasi, L., Pisterna, A., Zanardi, A., Fruttero, C., Beretta, G. D., Dusi, G., Campione, M., Gennari, A., Chiappetta, M. R., Perrone, F., & Di Maio, M. (2025). Inter-hospital heterogeneity in the authorizations of off-label cancer drugs: A project by Associazione Italiana di Oncologia Medica. Tumori Journal. https://doi.org/10.1177/03008916251386285

Vancouver

Valsecchi AA, Scaldaferri M, Tiseo M, Numico G, Russo G, Personeni N, et al. Inter-hospital heterogeneity in the authorizations of off-label cancer drugs: A project by Associazione Italiana di Oncologia Medica. Tumori Journal. 2025. doi:10.1177/03008916251386285

BibTeX
@article{Valsecchi2025,
  author = {Valsecchi, Anna Amela and Scaldaferri, Matilde and Tiseo, Marcello and Numico, Gianmauro and Russo, Gianluca and Personeni, Nicola and Blasi, Livio and Pisterna, Alessia and Zanardi, Alessandra and Fruttero, Claudia and Beretta, Giordano Domenico and Dusi, Giulia and Campione, Marina and Gennari, Alessandra and Chiappetta, Maria Rachele and Perrone, Francesco and Di Maio, Massimo},
  title = {Inter-hospital heterogeneity in the authorizations of off-label cancer drugs: A project by Associazione Italiana di Oncologia Medica},
  journal = {Tumori Journal},
  year = {2025},
  doi = {10.1177/03008916251386285}
}
Kostenlos starten →